Public Data
4 samples
Isoliensinine affects the expression of mRNA and miRNA in oral squamous cell carcinoma HSC-3 cells
Accession: SRP500138
Published: 2024
cell line
bioactive entity
canine oral squamous cell carcinoma
Public Data
29 samples
Braf-mutant Schwann cells divert to a repair phenotype to induce congenital demyelinating neuropathy [SCP]
Accession: SRP496728
Published: 2024
cell line
gene, gene: overexpression
Public Data
10 samples
The Regulating Markers for Brucella spondylitis and Tuberculous spondylitis
Accession: SRP495012
Published: 2024
primary tissue
blood
Brucella, normal, ...
Public Data
8 samples
Genome-wide studies identify the role of PML/RARa phase separation in PML/RARa-driven transcriptional dysregulation.
Accession: SRP494467
Published: 2024
cell line
gene, gene: overexpression, ...
acute promyelocytic leukemia
Public Data
10 samples
Unveiling a Novel Mechanism Regulating HER2-Induced Phenotypic Plasticity in Breast Cancer Cells
Accession: SRP489967
Published: 2024
cell line
gene, gene: overexpression
mammary gland
Public Data
6 samples
PD-L1 and IFN-? modulate Non-Small Cell Lung Cancer (NSCLC) Cell Plasticity responsible for ICI-Resistance
Accession: SRP488413
Published: 2024 in J Transl Med
primary cells
bioactive entity
lung
non-small cell lung carcinoma
Public Data
6 samples
Knockdown and sequencing of Nogo-B in endothelial cells
Accession: SRP485100
Published: 2024
cell line
gene, gene: sirna
blood vessel
diabetic kidney disease
Public Data
12 samples
Pharmacological inhibition of SIRT1 limits the growth of ovarian granulosa cell tumors in vitro and in preclinical mouse models
Accession: SRP482580
Published: 2024 in Mol Cancer Ther
cell line
bioactive entity
Public Data
18 samples
Transcriptomic changes in a KRASG12C mutant cell line (H358 cells) treated with the allosteric SHP2 inhibitor TNO155 for different times
Accession: SRP484187
Published: 2024
cell line
bioactive entity
Public Data
24 samples
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclib
Accession: SRP480634
Published: 2024 in iScience
cell line
bioactive entity
glioma
Public Data
4 samples
IGF2BP3 mediates m6A-modified E2F2 stability to affect neuroblastoma progression [RNA-seq]
Accession: SRP482619
Published: 2024
cell line
gene, gene: shrna
neuroblastoma
Public Data
8 samples
IRF3 activates RB to authorize cGAS-STING-induced senescence and mitigate liver fibrosis
Accession: SRP480531
Published: 2024
cell line
bioactive entity
Public Data
12 samples
First-in-class humanized antibody against alternatively spliced tissue factor augments anti-metastatic efficacy of chemotherapy in a preclinical model of pancreatic ductal adenocarcinoma
Accession: SRP480728
Published: 2024 in Int J Mol Sci
xenograft
bioactive entity
pancreas
pancreatic ductal adenocarcinoma
Public Data
169 samples
Sex-specific and multiomic integration enhance accuracy of peripheral blood biomarkers of major depressive disorder [RNA-Seq]
Accession: SRP479443
Published: 2024 in EBioMedicine
primary, primary tissue
blood
major depressive disorder
Public Data
28 samples
Aberrant lipid metabolism in macrophages is associated with granuloma formation in sarcoidosis
Accession: SRP479572
Published: 2024 in Am J Respir Crit Care Med
primary cells
bioactive entity
blood
normal, sarcoidosis